ALBO Albireo Pharma Inc

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.

$35.52  +0.78 (2.25%)
As of 06/23/2021 15:59:50 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  19,194,729
Average volume:  187,773
Market cap:   $678,533,670
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    01345P106
ISIN:        US01345P1066
Sedol:      BYMP0T9
Valuation   (See tab for details)
PE ratio:   -5.56
PB ratio:   4.51
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy